Navigation Links
Auxilium Pharmaceuticals, Inc. Updates Launch Progress of XIAPEX® in EU
Date:5/20/2011

MALVERN, Pa., May 20, 2011 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced that the Company received a $7.5 million regulatory milestone from Pfizer, Inc. (Pfizer) following the first sale of XIAPEX® in Germany, a major EU market.  XIAPEX is now available for sale in the United Kingdom, Germany, Denmark, Sweden, Finland, Norway and Austria.  XIAPEX is a new non-surgical treatment option for Dupuytren's contracture in adult patients with a palpable cord and is the first injectable treatment to be approved in the EU for the treatment of Dupuytren's contracture.

(Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO)

Auxilium has now earned $52.5 million of regulatory milestones related to the Dupuytren's contracture indication and is eligible to receive up to $22.5 million in additional regulatory milestone payments for this indication.  The remaining $22.5 million will be paid in $7.5 million increments, following Pfizer's first sale of XIAPEX in each of the remaining major markets of the EU.  Pfizer has the marketing rights to collagenase clostridium histolyticum for Dupuytren's contracture in the 27 countries of the EU and 19 Eurasian countries.  

"We are pleased to see our close collaboration with Pfizer bring XIAPEX, a novel, non-surgical alternative to new patients suffering from the debilitating effects of Dupuytren's contracture in additional European countries," said Armando Anido, Chief Executive Officer and President of Auxilium.

Prices for XIAPEX have been published in Austria, Denmark, Norway and the United Kingdom and are in the range of U.S.$1,000 to U.S.$1,400  per vial at current exchange rates.

Dupuytren's disease is a slowly progressive connective tissue disorder that can cause an affected finger to bend into the palm of
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Auxilium Pharmaceuticals, Inc. Announces First Quarter 2011 Financial Results and Operational Highlights
2. Auxilium Pharmaceuticals to Announce First Quarter 2011 Results and Conduct Conference Call on Monday, May 9, 2011
3. Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2010 Financial Results, Guidance for 2011
4. Auxilium Pharmaceuticals to Announce Fourth Quarter and Full Year 2010 Results and Conduct Conference Call on Thursday, February 10, 2011
5. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2011 Financial Results
6. Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2011 Financial Results
7. Optimer Pharmaceuticals, Inc. Announces Exercise in Full of Underwriters Option to Purchase Additional Shares and Closing of Public Offering of Common Stock
8. ANGIOTECH PHARMACEUTICALS, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2010
9. Omthera Pharmaceuticals, Inc. Announces Initiation of the ECLIPSE Trial: Epanova Compared to Lovaza In a Pharmacokinetic Single-dose Evaluation
10. Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information
11. Biostar Pharmaceuticals, Inc. Expands Rural Network by Over 21% in Third Quarter 2010; Brings Total Number of Locations to 8,500
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... (PRWEB) July 28, 2014 The Workgroup ... authority on the use of health IT to create ... Health Plan Identifier (HPID) Workgroup has developed an ... Health Plan and Payer?” The HPID Workgroup, a part ... with the Centers for Medicare and Medicaid Services (CMS) ...
(Date:7/28/2014)... 2014 Research and Markets has ... Market 2014-2018" report to their offering. ... synthetic biology covers the designing and engineering of completely ... the redesigning of natural biological systems that provide improved ... form of extreme genetic engineering because it not only ...
(Date:7/28/2014)... Hershey, PA & Boston, MA (PRWEB) July 28, 2014 ... into collaboration agreements with two researchers to further develop ... and deadly malignant brain tumor, in combination with their ... executed by ITI and Duke University, are based on ... MHSc, Chief, Division of Neurosurgery at The Preston Robert ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 The global ... billion by 2020, according to a new study by ... the rising demand for effective vaccines and drugs in ... unmet medical needs is expected to drive market demand ... to enhance agricultural productivity via the use of genetically ...
Breaking Biology Technology:WEDI’s HPID Workgroup Announces Release of Issue Brief: “What is the Difference Between a Health Plan and Payer?” 2Global Synthetic Biology Market 2014-2018 2String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 2String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 3String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 4Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 2Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 3Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 4
... Overview , ... mixtures using isotope coded affinity tags is to correctly identify ... a spectrum generated by mass spectrometry. Because MALDI-TOF mass spectrometry ... it can be used to quickly screen the ICAT reagent ...
... Lamor, V. Pop and G. Bican, Doping Control Laboratory, Bucharest, Romania ... , Corticosteroids are a class ... potent drugs in the treatment of inflammations and asthma [1]. Corticosteroids ... an athletes ability to concentrate and perform in endurance and power ...
... Morrow, and B. Alexander, TexMS Analytical Services, Houston, TX C. , ... CA , Introduction , ... the pigments in fruits, vegetables, and herbs. There have been reports of ... illnesses, such as rheumatoid arthritis, cancer, cataracts, anxiety, and depression. The objective ...
Cached Biology Technology:Achieving Reliable Protein Quantitation Results Using ICAT Reagents, MALDITOF Mass Spectrometry, and Advanced Data Interpretation Tool 2Achieving Reliable Protein Quantitation Results Using ICAT Reagents, MALDITOF Mass Spectrometry, and Advanced Data Interpretation Tool 3Screening of Corticosteroids in Urine by Negative Atmospheric Pressure Chemical Ionization LC/MS/MS 2Screening of Corticosteroids in Urine by Negative Atmospheric Pressure Chemical Ionization LC/MS/MS 3Screening of Corticosteroids in Urine by Negative Atmospheric Pressure Chemical Ionization LC/MS/MS 4Quantitation of a Dinitro Flavonoid (DNF) in Rat Plasma Using the Varian 1200L LC/MS/MS System 2Quantitation of a Dinitro Flavonoid (DNF) in Rat Plasma Using the Varian 1200L LC/MS/MS System 3
(Date:7/28/2014)... (July 28, 2014) Rice University researchers are using ... varying flexibility that can be used as microscale models ... that "bead-spring" polymers, introduced as theory in the 1950s, ... required and should be of interest to materials scientists ... work led by Rice chemical and biomolecular engineer Sibani ...
(Date:7/28/2014)... A powerful new tool that can help advance ... green and renewable bioenergy, has been developed by ... Joint BioEnergy Institute (JBEI), a multi-institutional partnership led ... JBEI researchers have developed an assay that enables ... nucleotide sugar transporters, critical components in the biosynthesis ...
(Date:7/28/2014)... the body,s natural virus killers to prevent and treat ... the strong inflammatory response these molecules can arouse as ... conducted by scientists at the Weizmann Institute and the ... the activity of these molecules interferons around ... the course of the disease. Their research appeared in ...
Breaking Biology News(10 mins):Seeing is bead-lieving 2How sweet it is 2How sweet it is 3Interfering with interferon 2
... used for the treatment of chronic obstructive pulmonary ... not well-controlled on low doses of inhaled corticosteroids, ... and Blood Institute (NHLBI), part of the National ... that tiotropium bromide might provide an alternative to ...
... Lake City, September 17, 2010Colon cancer is the second most ... 50,000 deaths each year. It has been known for some ... than 85 percent of all sporadic colon cancers. Now researchers ... in a study featured today in Cell the mechanism by ...
... This press relase is available in ... red coloration of pickles, skin during fermentation may actually ... to a U.S. Department of Agriculture (USDA) study. ... coloring when combined with tartrazine, a yellow food-coloring agent ...
Cached Biology News:Possible alternate therapy for adults with poorly controlled asthma 2Possible alternate therapy for adults with poorly controlled asthma 3Mechanism behind demethylation pinpointed in APC gene mutants 2Pickle spoilage bacteria may help environment 2
Protein Kinase D2 Immunogen: Human protein kinase D2. Storage: -20 C, Avoid Freeze/Thaw Cycles...
...
... Upright Freezer Inventory Storage Racks ... configurations available to fit all makes ... refrigerators. Made of high quality ... 3" high fiberboard, stainless steel or ...
Many mammalian cell types and experimental situations create challenges for standard transfection experiments. The ViraPower Lentiviral Expression System overcomes these challenges with efficient vir...
Biology Products: